Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth

Globenewswire_fr13 Nov 2026, 18:02 PKTvia NewsData.io

WOBURN, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology, today reported financial results for the quarter ended September 30, 2026.

Read the full story on Globenewswire_fr

Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.